Your institution may have access to this item. Find your institution then sign in to continue.
Title
New Drug Information.
Abstract
The article provides information on the new immunomodulator Extavia developed by Novartis AG. Information about the drug's active ingredient, indication and precautions is given. Drug dosage for adults and children is provided. Clinical trials are also reviewed. In addition, adverse physiological reactions of drug are noted.